[HTML][HTML] PD-1/PD-L1 pathway: current researches in cancer

Y Han, D Liu, L Li - American journal of cancer research, 2020 - ncbi.nlm.nih.gov
Cancer immunotherapy has been accompanied by promising results over the past few
years. Programmed Cell Death Protein 1 (PD-1) plays a vital role in inhibiting immune …

[HTML][HTML] Regulation of PD-L1: a novel role of pro-survival signalling in cancer

J Chen, CC Jiang, L Jin, XD Zhang - Annals of oncology, 2016 - Elsevier
Evasion of immune system is a hallmark of cancer, which enables cancer cells to escape the
attack from immune cells. Cancer cells can express many immune inhibitory signalling …

PD-1/PD-L1 in cancer: pathophysiological, diagnostic and therapeutic aspects

E Munari, FR Mariotti, L Quatrini, P Bertoglio… - International journal of …, 2021 - mdpi.com
Immune evasion is a key strategy adopted by tumor cells to escape the immune system
while promoting their survival and metastatic spreading. Indeed, several mechanisms have …

Regulation of PD-L1 expression in the tumor microenvironment

M Yi, M Niu, L Xu, S Luo, K Wu - Journal of hematology & oncology, 2021 - Springer
Abstract Programmed death-ligand 1 (PD-L1) on cancer cells engages with programmed
cell death-1 (PD-1) on immune cells, contributing to cancer immune escape. For multiple …

Current insight into the regulation of PD-L1 in cancer

Z Liu, X Yu, L Xu, Y Li, C Zeng - Experimental hematology & oncology, 2022 - Springer
The molecular mechanisms underlying cancer immune escape are a core topic in cancer
immunology research. Cancer cells can escape T cell-mediated cellular cytotoxicity by …

[HTML][HTML] Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer

X Zhu, J Lang - Oncotarget, 2017 - ncbi.nlm.nih.gov
The membrane-bound molecules programmed death 1 (PD-1) and its ligand PD-L1 (PD-
1/PD-L1) belong to the immune checkpoint pathway. PD-1 pathway downregulates effector …

[HTML][HTML] Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?

C Solinas, M Aiello, E Rozali, M Lambertini… - Translational …, 2020 - Elsevier
Programmed cell death-ligand 2 (PD-L2) is one of the two ligands of the programmed cell
death-1 (PD-1) receptor, an inhibitory protein mainly expressed on activated immune cells …

[HTML][HTML] PD-1 and its ligands are important immune checkpoints in cancer

Y Dong, Q Sun, X Zhang - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract Checkpoint programmed death-1 (PD-1)/programmed cell death ligands (PD-Ls)
have been identified as negative immunoregulatory molecules that promote immune …

PD‐1/PD‐L1 pathway: basic biology and role in cancer immunotherapy

A Salmaninejad, SF Valilou… - Journal of cellular …, 2019 - Wiley Online Library
Over the course of past few years, cancer immunotherapy has been accompanied with
promising results. However, preliminary investigations with respect to immunotherapy …

[HTML][HTML] The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells

Q Lin, X Wang, Y Hu - Cancer Letters, 2023 - Elsevier
The immunosuppressive molecule programmed death-ligand 1 (PD-L1) is frequently
upregulated in human cancers. Binding of PD-L1 to its receptor, programmed death-1 (PD …